Synthonics, Inc. is a privately-owned specialized pharmaceutical company that focuses on the exploration and advancement of patentable medications integrating our exclusive metal coordination chemistry. We attach metals to established pharmaceutical compounds to generate novel products with enhanced absorption and delivery properties, along with superior therapeutic advantages compared to their predecessors. Our proprietary chemistry is patented in the form of new compositions of matter involving drugs.